Cat. No.: DAB-0011069
| Product Information | |
|---|---|
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Host Species | Mouse |
| Reactivity | Human |
| Applications | Flow Cyt (Intra) |
| Product Description | Mouse monoclonal antibody [BS375] to proBDNF. |
| Format | Lyophilized: Spin vial briefly before opening. Reconstitute in 100 µL of sterile water. Centrifuge to remove any insoluble material. Final buffer contains no preservatives. After reconstitution divide into aliquots and store at -20ºC for a higher stability. Antibody contains no preservatives. Store at 4ºC with an appropriate antibacterial agent. Use sterile methods. Highest purity Glycerol (1: 1) may be added for an additional stability when stored at refrigerated or freezing temperatures. |
| Purity | Affinity purity |
| Target Information | |
|---|---|
| Target Name | BDNF |
| UniProt No. | P23560 |
| Gene ID | 627 |
| Gene Description | During development, promotes the survival and differentiation of selected neuronal populations of the peripheral and central nervous systems. Participates in axonal growth, pathfinding and in the modulation of dendritic growth and morphology. Major regulator of synaptic transmission and plasticity at adult synapses in many regions of the CNS. The versatility of BDNF is emphasized by its contribution to a range of adaptive neuronal responses including long-term potentiation, long-term depression, certain forms of short-term synaptic plasticity, as well as homeostatic regulation of intrinsic neuronal excitability. |
| Shipping & Storage | |
|---|---|
| Shipping | Shipped at 4 °C. |
| Storage Instructions | Store at +4 °C short term (1-2 weeks). Upon delivery aliquot. Store at -20 °C long term. Avoid freeze / thaw cycle. |
| Storage Buffer | pH: 7; Constituents: PBS, 3% TrehaloseLyophilized without; Preservatives. |
Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
